• Healthcare Professionals
• Therapeutic Focus
  • Central Nervous System Disorders
    • Obstructive Sleep Apnea
    • Shift Work Sleep Disorder
    • Narcolepsy
    • Epilepsy
  • Oncology
    • Acute Promyelocytic Leukemia
    • Non-Hodgkin's Lymphoma
    • Chronic Lymphocyctic Leukemia
  • Pain
    • Breakthrough Pain in Patients with Cancer
    • Muscle Spasm Associated with Musculoskeletal Conditions
• Product Information Request
• Our Products
  • Drug Delivery Technologies
  • State Compliance
• CephalonCares Foundation Patient Assistance Programs
• Reimbursement Assistance
• Clinical Trials Information

Home > Healthcare Professionals > Clinical Trials Information

Clinical Trials Information

For information about clinical trials using Cephalon products--sponsored by institutions, the US government, and Cephalon--consult the list of links to the National Institute of Health www.clinicaltrials.gov website.

Click on the title of the study to learn about recruitment status, sites, criteria for participation, and contact information.

Cephalon is recruiting patients for clinical trials in the following areas:

Cancer

• Study to Evaluate the Safety and Efficacy of Armodafinil Treatment for Patients With Fatigue Associated With Taxane Chemotherapy
• Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)
• Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Patients With HER2-Positive Breast Cancer
• Study of Bendamustine Hydrochloride in Combination With Rituximab in the Treatment of Patients With Relapsed/Refractory Mantle Cell Lymphoma
• Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
• Study to Investigate the Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy
• Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer
• Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors

Central Nervous System

• Study to Evaluate the Effects of Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance in Adults With OSAHS Who Use nCPAP Therapy
• Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia
• Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Pain

• Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients